This program has been approved by the Pennsylvania Continuing Legal Education Board for 5 hours of CLE credit in substantive law and 1 hour of integrated ethics. You must attend the entire program to receive the ethics credit.
Don’t miss this third annual, day-long event! Join our panel of experts and hear about the latest developments in Pennsylvania’s medical marijuana and hemp program. Whether you represent a grower, dispensary, government entity, patient, or are just curious and wanting to learn more about this emerging industry, you will want to be among the attendees at this event. With leading experts in the legal, medical and government sectors, the Symposium will provide a multifaceted look at how the industry and Pennsylvania’s implementation of its program has and will continue to impact the state.
This event will feature two tracks, one covering medical marijuana and the other covering hemp.
Our Keynote Speaker will be Assistant General Counsel, Mia T. Dinh, Esq. from the USDA Office of General Counsel. She will present:USDA’s Rule on the Domestic Hemp Production Program:**
From the United States Department of Agriculture’s Office of General Counsel, Ms. Mai Dinh, Esq. has led the creation of some of the most important guidance documents in the hemp industry. Directly overseeing the drafting of the USDA’s 2019 Interim Rule concerning Hemp, Ms. Dinh will share her experiences and expertise with the audience in this year’s Keynote Address. Bring your questions and be prepared to hear directly from those involved with the process about the ins and outs of this new emerging market and how the Federal Government is working to stay ahead of the curve.
Medical Marijuana Track:
In the Books and on the Street: Regulations and the Medical Marijuana Act:
Attorneys and permitted medical marijuana operators team up to present a seminar addressing the regulations promulgated under Pennsylvania’s Medical Marijuana Act. The course will combine detailed legal analysis with real-world perspectives to give the audience an opportunity to hear what issues are being encountered daily, and the means by which attorneys can help their clients navigate the regulations to find effective solutions.
Pennsylvania’s Medical Marijuana Act: A Litigation Overview: **
Even before permits were awarded under Pennsylvania’s Medical Marijuana Act, issues were already being teed up for litigation. Now, nearly three years after the first permits were awarded, some operators have found themselves mired in complex litigation often involving administrative procedures, the rules of which can look quite different than your typical courtroom. In this session you will hear directly from the attorneys litigating these issues on the front lines. The session will examine some of the most recent cases being litigated while simultaneously reviewing the detailed rules of procedure governing medical marijuana litigation before the Department of Health.
Hazy Issues: Education, Employment and Workers’ Comp:
Ever since PA’s Medical Marijuana Act was enacted, there has been little or inconsistent guidance on how the law impacts employees and employers as well as in the school setting. This session will examine both national, state and local opinions in the areas of employment, workers’ compensation and education issues. This class will review what protections PA’s Medical Marijuana Act provides or doesn’t provide in these practice areas, and why the answers may be more hazy than clear. Whether you represent an employee, employer, school or student, this class will alert you to the legal challenges in these areas, provide tips to navigate through these murky waters and assist to prepare your legal arguments.
Diversity Issues in the Marijuana Industry:
For decades, black and brown communities have been disproportionately affected by the criminalization of cannabis. Studies have repeatedly shown that, while Americans of all races and ethnicities use illicit drugs at roughly the same rates, African Americans are 3-4 times more likely to be arrested and imprisoned for drug use as compared to their white counterparts. This imbalance had continued even in the face of criminal justice reform. This panel will discuss both the consequences of cannabis prohibition, and the path forward.
Cannabis 2020: Roundtable Discussion:**
Its 2020 and the cannabis industry is growing up quickly. International mergers, billion-dollar valuations, and, of course, legal headaches. This panel, consisting of some of the foremost authorities from across the country, will take a step back and examine the current status of the cannabis industry and try to project what the next decade will bring. Is national adult-use on the horizon? Will hemp push the marijuana market aside? Come hear the answers to these questions and be part of a fascinating discussion on cannabis’ next ten years.
2014 and 2018 Farm Bill: An Intro to Regulated Hemp:**
This session will cover the foundational information necessary to understand the recently evolving hemp industry and the dramatic changes presented by the two most recent United States Farm Bills. The panel, consisting of some of the most influential hemp operators in the country, will discuss the key provisions from the Farm Bill and how in a matter of a few quick years – a plant went from a Schedule 1 Substance to now legally being grown on tens of thousands of acres across the country.
FDCA and the FDA’s Position on CBD:
CBD products are everywhere. But are they legal? This panel, including top regulatory and cannabis attorneys from across the country, will dive deep into the confusing and often conflicting legal picture surrounding CBDs and other hemp derived products. The session will address medical claims made by hemp producers by examining the intersection between the Food Drug and Cosmetic Act and the emerging hemp industry. The panel will also provide an overview of recent enforcement actions brought by the FDA.
HBCU & Agribusiness in the U.S.:**Pennsylvania’s Hemp Program:**
HBCUs are uniquely positioned to serve as anchor institutions in soil rich regions and to lead agribusiness' reduction of the current use of energy and water, particularly in the commercially farmed south. Industrial hemp is a bioaccumulator that sequestors a significant amount of carbon, meaning HBCU research and pilot programs could help increase the diversity of scientists working hard to manage disruptive changes to the climate. Because industrial hemp represents a rapidly growing, quickly renewable raw material it could be used to produce a variety of products that (with thoughtful planning) and could help strengthen HBCUs and their service communities, as well as bring American farming back to life as a generational economic legacy.
Pennsylvania’s hemp program is open for business. In January, the Department of Agriculture made available permits for the growing hemp during the 2020 season. The Department also, for the first time, created a new permit for the processing hemp. While this industry is ripe with opportunities, growing and processing hemp remains risky business. One small mistake, and an entire field can be deemed illegal and ordered for destruction. This session will examine the specific issues governing hemp growing and production in the Commonwealth.
**Indicates the sessions that will be simulcast
All attendees will receive the course materials as a digital book. A printed copy of the course book is available, at a discount to attendees, for $60. Additional copies are available at full price. If you wish to purchase the printed version of the course book, please call PBI Customer Service at 800-932-4637. Printed versions of the course book will not be distributed at the course; please allow up to two weeks after the program for the printed versions of the course book to be shipped.